4.5 Article

Treatment of malignant, non-resectable, epithelial origin esophageal tumors with the humanized anti-epidermal growth factor antibody nimotuzumab combined with radiation therapy and chemotherapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Cardiac & Cardiovascular Systems

Evidence-Based Surgical Treatment of Esophageal Cancer: Overview of High-Quality Studies

Sjoerd M. Lagarde et al.

ANNALS OF THORACIC SURGERY (2010)

Article Oncology

The global burden of cancer: priorities for prevention

Michael J. Thun et al.

CARCINOGENESIS (2010)

Review Pharmacology & Pharmacy

Hsp90 as a therapeutic target in patients with oesophageal carcinoma

Simon Ekman et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2010)

Article Oncology

DDEC: Dragon database of genes implicated in esophageal cancer

Magbubah Essack et al.

BMC CANCER (2009)

Article Gastroenterology & Hepatology

Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?

Stephan Kersting et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)

Review Medicine, Research & Experimental

Antibodies targeting cancer stem cells A new paradigm in immunotherapy?

Mahendra P. Deonarain et al.

Article Oncology

Developments in Treatment of Esophageal/Gastric Cancer

Wei Liu et al.

CURRENT TREATMENT OPTIONS IN ONCOLOGY (2008)

Article Medicine, General & Internal

Safety-related regulatory actions for biologicals approved in the United States and the European Union

Thijs J. Giezen et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)

Article Oncology

Esophageal cancer: Adjuvant therapy

Geoffrey Y. Ku et al.

CANCER JOURNAL (2007)

Review Chemistry, Medicinal

Hsp90: A novel target for cancer therapy

David B. Solit et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2006)

Article Oncology

New guidelines to evaluate the response to treatment in solid tumors

F Duffaud et al.

BULLETIN DU CANCER (2000)

Article Oncology

New guidelines to evaluate the response to treatment in solid Tumors

P Therasse et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)